Maker of Costly Hepatitis C Drug Sovaldi Strikes Deal on Generics for Poor Countries
Monday, September 15, 2014 - 18:00
in Health & Medicine
The agreements between Gilead Sciences and seven Indian firms seek to provide treatment to those infected in 91 developing nations.